好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

A Randomized Placebo-Controlled Trial of Rituximab in IgM Anti-Myelin-Associated Glycoprotein Antibody Demyelinating Neuropathy
Peripheral Nerve
(-)
001
Authors/Disclosures
Jean-Marc Leger, MD, FAAN (Hospital de la Salpetriere) No disclosure on file
Gian D. Pal, MD (Rutgers University) Dr. Pal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. Dr. Pal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Pal has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for CLRM Law. Dr. Pal has stock in Baudax Bio. The institution of Dr. Pal has received research support from National Institutes of Health. The institution of Dr. Pal has received research support from Parkinson's Foundation. Dr. Pal has received personal compensation in the range of $500-$4,999 for serving as a Consultant with RKV Firm.
Karine Viala (GH Pitie Salpetriere) No disclosure on file
Brenda L. Wong, MD (University of Massachusetts Medical School) No disclosure on file
No disclosure on file
Alain Creange (Hopital Henri Mondor) No disclosure on file
Jean M. Vallat, MD (University Hospital) No disclosure on file
Jean Pouget, MD, PhD (CHU La Timone) No disclosure on file
Pierre Clavelou, MD, PhD (Hopital Gabriel Montpied) Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Benoit Marin No disclosure on file